Hydrochloric Acid

Hydrochloric Acid

SCHEMBL604164

N#Cc1ccc(-[n+]2ccc(-c3cc[n+](CCP(=O)(O)O)cc3)cc2)cc1.[Cl-].[Cl-]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ PTPN5 P54829 1/20 0.38
▸ MMP2 P08253 2/20 0.37
▸ MMP3 P08254 1/20 0.33
▸ POLB P06746 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ LOXL2 Q9Y4K0 1/20 0.32
▸ ABCB1 P08183 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ ABCG2 Q9UNQ0 1/20 0.30
▸ CYP2A6 P11509 1/20 0.30
▸ ENPP2 Q13822 1/20 0.30
▸ SAE1 Q9UBE0 1/20 0.30
▸ UBA2 Q9UBT2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10000931 0.99 PTPN5 (0.38) PTPN5MMP2MMP3POLBMAPT
Hydrochloric Acid SCHEMBL600761 0.82 ALDH1A1 (0.39) MMP2MMP3MAPT
Hydrochloric Acid SCHEMBL194414 0.81 PGK1 (0.37) PTPN5ENPP2
SCHEMBL4330743 0.80 ALDH1A1 (0.36) PTPN5MMP2MMP3MAPT
Hydrochloric Acid SCHEMBL210855 0.79 MEN1 (0.38) MAPT
Hydrochloric Acid SCHEMBL2463206 0.79 MMP3 (0.45) PTPN5MMP3LOXL2CYP2A6ENPP2
SCHEMBL12324392 0.79 — —
Hydrochloric Acid SCHEMBL601282 0.78 ACHE (0.40) —
Hydrochloric Acid SCHEMBL2259936 0.77 MMP2 (0.39) PTPN5MMP2MMP3
SCHEMBL1226951 0.77 MEN1 (0.39) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8786932-B2 Advanced electrode structures and electrochromic devices NTERA, INC. (US) 2014-07-22 — — US claimed
US-20120038967-A1 ADVANCED ELECTRODE STRUCTURES AND ELECTROCHROMIC DEVICES NTERA LIMITED (IE) 2012-02-16 — — US claimed
US-20090259042-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2009-10-15 — — US claimed
US-20060110638-A1 Electrochromic compounds NTERA LIMITED (IE) 2006-05-25 — — US claimed
EP-1594938-A1 ELECTROCHROMIC COMPOUNDS Ntera Limited (IE) 2005-11-16 — — EP claimed
WO-2004067673-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2004-08-12 — — WO claimed
EP-1443091-A1 Electrochromic compounds Ntera Limited (IE) 2004-08-04 — — EP claimed
US-8999430-B2 Method of manufacturing display element KONICA MINOLTA HOLDINGS, INC. (JP) 2015-04-07 — — US disclosed
US-8786932-B2 Advanced electrode structures and electrochromic devices NTERA, INC. (US) 2014-07-22 — — US disclosed
EP-2149816-B1 METHOD OF MANUFACTURING AN ELECTROCHROMIC DISPLAY ELEMENT KONICA MINOLTA HOLDINGS INC (JP) 2014-05-07 — — EP disclosed
US-20120038967-A1 ADVANCED ELECTRODE STRUCTURES AND ELECTROCHROMIC DEVICES NTERA LIMITED (IE) 2012-02-16 — — US disclosed
US-8014056-B2 Display element and method of driving the same KONICA MINOLTA HOLDINGS, INC. (JP) 2011-09-06 — — US disclosed
US-8004742-B2 Electrochromic display device KONICA MINOLTA HOLDINGS, INC. (JP) 2011-08-23 — — US disclosed
US-7525716-B2 Display device and display apparatus RICOH COMPANY, LTD. (JP) 2009-04-28 — — US disclosed
EP-2040115-A1 ELECTROCHROMIC DISPLAY DEVICE Konica Minolta Holdings, Inc. (JP) 2009-03-25 — — EP disclosed
US-7489432-B2 Electrochromic display device and display apparatus RICOH COMPANY, LTD. (JP) 2009-02-10 — — US disclosed
US-20060215250-A1 Electrochromic display device and display apparatus RICOH COMPANY, LTD. (JP) 2006-09-28 — — US disclosed
US-20060204866-A1 Display device and display apparatus RICOH COMPANY, LTD. (JP) 2006-09-14 — — US disclosed
US-20060110638-A1 Electrochromic compounds NTERA LIMITED (IE) 2006-05-25 — — US disclosed
EP-1443091-A1 Electrochromic compounds Ntera Limited (IE) 2004-08-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090259042-A1 ELECTROCHROMIC COMPOUNDS ETV6, HCN2, EED PTPN5 2907/4885MMP2 2943/4885MMP3 1976/4885
US-20060110638-A1 Electrochromic compounds ETV6, HCN2, EED PTPN5 2907/4885MMP2 2943/4885MMP3 1976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback